Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × Filgrastim × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Leukemia, Biphenotypic, Acute 6 Myelodysplastic Syndromes 5 Hodgkin Disease 5 Breast Neoplasms 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Hematologic Neoplasms 4 Burkitt Lymphoma 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Medulloblastoma 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia 2 Triple Negative Breast Neoplasms 1 Teratoma 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Osteosarcoma 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1

Interventions

pembrolizumab 2 Specimen Handling 2 Radiotherapy 2 Radiation 2 Doxorubicin 2 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 futibatinib 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Erlotinib Hydrochloride 1 Dactinomycin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡